New Study Reconfirms Long-Term Strength of Biodesign™ Hernia Graft – Cook Medical
Posted Mar 24 2009 3:57pm
A few weeks ago I had an interview with Mark Bleyer, President of Cook Biotech and Mike Hiles, Ph.D., VP of Research and Lead Research and this was exactly the topic we discussed, regenerational medicine, and below is a short informational clip from our discussion. Regenerational medicine is something that is here today and there are many who perhaps are not aware of how this technology can offer a patient a considerable upgraded quality of life versus some of the older tissue repair or surgical procedures used. If you are not familiar with regenerational medicine, the link below will in fact open your eyes as to what is being done, and this is available today. Watch the video at the link below as well and be amazed at how fast it is moving and the role that Biodesign plays. BD
“SIS Composition As a natural biomaterial, SIS is primarily protein with secondary amounts of carbohydrates and lipids.
SIS is obtained from the intestine using a process that retains the natural composition of matrix molecules such as collagen (Types I, III, VI), glycosaminoglycans, (hyaluronic acid, chondroitin sulfate A and B, heparin, and heparan sulfate), proteoglycans, and glycoproteins (fibronectin), which are known to have important roles in host tissue repair and remodeling.”
The Cook Biotech products are known in the medical community as Biodesign and have many applications.
Biodesign products are used for procedures such as:
Pelvic floor reconstruction
Treating pelvic organ prolapse
Oral surgery applications (known as “Oasis”)
I wanted to know if Biodesign was similar to a graft (of sorts) and if there was the potential for infection.
I was informed that Biodesign actually combines the best features of biologic grafts and synthetic mesh, offering physicians and patients a safer and more adaptable alternative for the human body. BD
Bloomington, Ind. – March 23, 2009 – A five-year study confirms the long-term strength and durability of the Biodesign Hernia Graft, Cook Medical, a world leader in advanced tissue repair, announced today.
The study, the largest published series with the longest follow-up time for a biologic mesh used in hernia repair, demonstrated that the Biodesign Hernia Graft possesses the clinically important strength of non-absorbable mesh, while providing the benefit of decreased infection complications of absorbable mesh.
“Biodesign’s long-term strength and ability to communicate with the body by signaling surrounding tissue to remodel are very important benefits for patients,” said Mark Bleyer, president of Cook Biotech. “The body uses the Biodesign graft as a lattice to guide tissue regeneration and heal itself with a repair that endures, as shown in the study.”
Morris E. Franklin, Jr., MD, et. al, of the Texas Endosurgery Institute, San Antonio, Texas, performed the study investigating the placement of biologic grafts to repair infected or potentially contaminated abdominal wall defects. Placement of the Biodesign Hernia Graft for incisional, umbilical, inguinal, femoral and parastomal hernias in potentially or grossly contaminated fields was thoroughly examined.
“The use of the Biodesign Hernia Graft in contaminated or potentially contaminated fields is a safe and feasible alternative to hernia repair with a minimal recurrence rate and satisfactory results in long-term follow-up,” said Franklin.
From May 2000 to October 2006, 133 procedures were performed on 116 patients. The study results were published in Surgical Endoscopy, Volume 22, No. 9, September 2008.
Manufactured in the Cook Biotech facility in West Lafayette, Ind., Biodesign is a breakthrough technology that provides signals and support for the body to restore itself. It incorporates the best attributes of a biologic graft–complete remodeling and resistance to infection–yet it’s easy to use, widely available and moderately priced.
About Cook Medical
Cook Medical was one of the first companies to help popularize interventional medicine, pioneering many of the devices now commonly used worldwide to perform minimally invasive medical procedures. Today, the company integrates device design, biopharma, gene and cell therapy and biotech to enhance patient safety and improve clinical outcomes in the fields of aortic intervention; interventional cardiology; critical care medicine; gastroenterology; radiology , peripheral vascular, bone access and oncology; surgery and soft tissue repair; urology; and assisted reproductive technology, gynecology and high-risk obstetrics. Cook is a past winner of the prestigious Medical Device Manufacturer of the Year Award from Medical Device & Diagnostic Industry magazine. For more information, visit www.cookmedical.com.
Media Contact: Marsha Dawes, Public Relations Coordinator,
Cook Medical 812-339-2235, ext. 2750; 812-320-6903 (cell);